ALX Oncology Holdings Inc.
ALXO
$2.11
-$0.07-3.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.00% | 21.77% | 16.14% | -3.50% | -31.50% |
| Total Depreciation and Amortization | -1.18% | 3.82% | 4.31% | 17.85% | 37.10% |
| Total Amortization of Deferred Charges | 5.45% | 5.93% | 6.00% | 13.04% | 53.89% |
| Total Other Non-Cash Items | -1.38% | 9.36% | 15.07% | 9.38% | 1.75% |
| Change in Net Operating Assets | -204.11% | -201.26% | -249.81% | -127.97% | 403.00% |
| Cash from Operations | 22.05% | 22.65% | 6.48% | -16.34% | -21.83% |
| Capital Expenditure | -134.46% | 50.96% | 64.91% | 64.69% | 130.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 382.72% | 196.91% | 88.77% | -49.93% | -70.31% |
| Cash from Investing | 362.57% | 203.20% | 93.15% | -49.62% | -67.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -72.49% | -110.31% | -113.14% | -88.43% | -22.73% |
| Issuance of Common Stock | -99.54% | -58.74% | -52.13% | 13,251.27% | 13,157.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 794.57% | 794.57% | 794.57% | 4,039.24% | -571.76% |
| Cash from Financing | -99.53% | -55.52% | -48.02% | 832.06% | 830.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.74% | 113.37% | 81.68% | 88.18% | 20.59% |